Private Placement in a Medical Technology Company
An innovative medical technology company in Singapore has finalised its prospectus for submission to the Australian Stock Exchange (ASX) this week, targeting its IPO in Australia at the end of July 2019.
Over the past 12 years since its inception, this company has accumulated a long track record of successful 10-year clinical outcomes, awards, certifications and recognition for its innovation. Now with its proprietary technology, proven use cases and very bright future prospects, the company is gearing up to go for an initial public listing in Australia.
The directors of Round Table participated in a private placement of this company in 2018, and have been working closely with the team towards a successful IPO.
Recently, this company has also been featured in The Edge Singapore, a weekly newspaper that provides in-depth and analytical coverage on business and investments within Singapore.
— Latest update: September 2019
Steady and stable growth – Reclaims Global (SGX: NEX)
Reclaims Global (SGX: NEX), an eco-friendly construction service provider specialising in recycling construction and demolition waste, customising excavation solutions and operating fleet management through environmentally-friendly methods is seeing a steady and stable growth in its share price since Round Table’s directors’ private placement in March 2019.
NEX corrected to a higher low of S$0.17 in April and within 3 weeks, printed an all-time high at S$0.24 with an exponential price growth of +40% from April’s low on the first week of May 2019. The price held steadily within a tight range throughout May and achieved another higher high of S$0.26, another 24% price growth from May’s low of S$0.21. The month ended with a very good trading volume, indicating further market interest in NEX.
Coupled with strong fundamentals and great technicals, NEX is expected to perform strongly in 2019.
View NEX on SGX